APVO: Aptevo O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
Aptevo Therapeutics daromadliligi ADAPT platformasiga asoslangan bo'lib, u yerda noyob antitelalar uzoq muddatli shartnomalar orqali asosiy hamkorlarni ta'minlaydi. PEG koeffitsiyenti o'zgarishlari tarixi baholash dinamikasini namoyish etadi, 0.00 esa joriy ko'rsatkichni shakllantiradi. ADAPTIR intellektual kapitali barqaror royalti to'lovlarini ta'minlaydi; biroq, tijorat mahsulotlarining yo'qligi kompaniyani operatsion pul oqimisiz investor mablag'lariga tayanishga majbur qiladi.
Aptevo Therapeutics (APVO) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- kompaniyaning balans qiymati tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati Aptevo Therapeutics|APVO - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi aptevotherapeutics.com|APVO - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Aptevo|APVO - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzlari Aptevo Therapeutics|Kritik likvidlik koeffitsiyenti aptevotherapeutics.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
APVO - Sof daromad|Kelajakdagi sof foyda Aptevo Therapeutics|APVO - P/E multiplikatori|Prognoz qilingan narx-foyda nisbati aptevotherapeutics.com|APVO - Narx-foyda va o‘sish multiplikatori|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Aptevo|APVO - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda Aptevo Therapeutics|APVO - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi aptevotherapeutics.com|APVO - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning prognoz qilingan ortishi Aptevo Therapeutics
Kompaniyaning umumiy tahlili:APVO - Aptevo Therapeutics, Inc.
Aptevo Therapeutics (APVO) kompaniyasining baholanishi antitelolarning klinik sinovlari muvaffaqiyatiga bog'liq bo'lib, bu foyda dinamikasini hisobga olmagan holda an'anaviy P/E koeffitsientini samarasiz qiladi. Ushbu ko'rsatkich bozor bahosini biznesning o'sish sur'atlari bilan solishtiradi, bunda birdan past qiymat aktivning fundamental jihatdan past baholanganligidan dalolat beradi. Hisoblangan PEG koeffitsientining tahlili investorlarga spekulyativ shovqinlarni filtrlash va adolatli investitsiya ufqini belgilash imkonini beradi.
Raqobatdosh kompaniyalar
ARGX (argenx N.V.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BNTX (BioNTech Group)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Abivax (ABVX)|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|protagonist-inc.com (PTGX) - Narx-foyda va o‘sish multiplikatori|Immunovant (IMVT) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Kiniksa Pharmaceuticals, Ltd.|Narx-foyda va o‘sish multiplikatori GRFS|PEG multiplikatori Adaptive Biotechnologies Inc.|Narxning foydaga va o‘sish sur’atiga nisbati Celldex Therapeutics (CLDX)|auriniapharma.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori BCRX (BioCryst Pharmaceuticals)|Vera Therapeutics Inc (VERA) - O‘sish sur’atiga tuzatilgan narx-foyda|Dianthus Pharma - PEG multiplikatori|PHVS - PEG multiplikatori|abcellera.com (ABCL) - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati TRML (tourmalinebio.com)|Narx-foyda va o‘sish multiplikatori PGEN|PHAR (Pharming Group NV) - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|PEG multiplikatori NKTR|UPB - O‘sish sur’atiga tuzatilgan narx-foyda|Zenas Biopharma Inc - Narx-foyda va o‘sish multiplikatori|immunome.com - Narxning foydaga va o‘sish sur’atiga nisbati|GOSS - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda KalVista Pharma|SEPN (Septerna Corp) - Narx-foyda va o‘sish multiplikatori|Pieris Corp - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narx-foyda va o‘sish multiplikatori SVRA|RIGL (rigel.com) - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|PEG multiplikatori ANAB|ATXS (Astria Therapeutics Inc) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori ENGN (enGene Bio)|rapt.com (RAPT) - O‘sish sur’atiga tuzatilgan narx-foyda|JBIO - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ACRS (aclaristx.com)|KYTX: PEG multiplikatori|Tiziana Life Sciences Ltd. (TLSA) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Cabaletta Bio, Inc|Ventyx Biosciences, Inc - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori THTX|AVTX - O‘sish sur’atiga tuzatilgan narx-foyda|Eledon Pharmaceuticals, Inc. - Narx-foyda va o‘sish multiplikatori|PEG multiplikatori Agenus, Inc. AGEN|CLYM: Narx-foyda va o‘sish multiplikatori|zurabio.com - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|ATYR: PEG multiplikatori|ADAG - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|IMA (ImageneBio) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori Shattuck Therapeutics (STTK)|Narxning foydaga va o‘sish sur’atiga nisbati Equillium, Inc. (EQ)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati connectbiopharm.com|PEG multiplikatori IMUX (Immunic)|PEG multiplikatori Atara Biotherapeutics, Inc. ATRA|IFRX - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati XFOR|ACET (adicetbio.com) - Narx-foyda va o‘sish multiplikatori|CELU (Celularity) - Narxning foydaga va o‘sish sur’atiga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati INmune Bio, Inc.|O‘sish sur’atiga tuzatilgan narx-foyda barinthusbio.com BRNS|Narxning foydaga va o‘sish sur’atiga nisbati Kezar Life Sciences, Inc. (KZR)|SABS: Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori AKTX (Akari Therapeutics plc)|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ENLV|Q32 Bio Corp - PEG multiplikatori|GOVX - PEG multiplikatori|Edesa Biotech (EDSA) - Narxning foydaga va o‘sish sur’atiga nisbati|iBio Inc - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Carisma Therapeutics Inc|Narx-foyda va o‘sish multiplikatori XTL Bio (XTLB)|PEG multiplikatori BOLT|PEG multiplikatori hcwbiologics.com (HCWB)|AIM ImmunoTech - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ADTX|GRI Bio Corp - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati XORTX Corp XRTX|Vyome Holdings Inc (HIND) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori revbiosciences.com|Narxning foydaga va o‘sish sur’atiga nisbati Indaptus Therapeutics, Inc.|Narx-foyda va o‘sish multiplikatori Scinai Immunotherapeutics Ltd (SCNI)|Narx-foyda va o‘sish multiplikatori CALI (CalciMedica, Inc.)|PEG multiplikatori affimed.com (AFMD)|Narxning foydaga va o‘sish sur’atiga nisbati Allakos ALLK|HOOK: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|IGM Bio - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda iTeos Therapeutics Inc|OCEA: PEG multiplikatori|TC BioPharm Ltd (TCBP) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Third Harmonic Bio
